Drug firm Panacea Biotec's standalone net loss narrowed to Rs 19.67 crore in the quarter ended on June 30, 2016, from Rs 36.90 crore in the same period last year.
Standalone total income from operations of the company stood at Rs 123.67 crore for the quarter under consideration as against Rs 124.84 crore for the same period year ago, Panacea Biotec said in a filing to BSE today.
Shares of Panacea Biotec today closed at Rs 130.20 on BSE, up 5.55 per cent from previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
